search
Back to results

The Brain Health Study: A Pragmatic, Patient-Centered Trial (eRADAR)

Primary Purpose

Dementia, Alzheimer Disease

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Brain Health Assessment
Sponsored by
University of California, San Francisco
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Dementia

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia Active patient at participating clinic Adequate data to calculate eRADAR score Exclusion Criteria: - Currently receiving hospice care

Sites / Locations

  • UCSF Primary Care at China Basin
  • Division of General Internal Medicine
  • Women's Health Primary CareRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Brain Health Intervention

Usual Care

Arm Description

Calculate eRADAR scores using EHR data to identify eligible individuals Invite eligible individuals for brain health assessment visit Enter results of brain health assessment visit into EHR Provide summary of results and recommended next steps to the Primary Care Physician and participant

Usual care Individuals who meet eligibility criteria will receive usual care.

Outcomes

Primary Outcome Measures

New dementia diagnosis
Rate of new dementia diagnosis identified from the electronic health record (EHR) using prespecified set of ICD-10 codes

Secondary Outcome Measures

Number of primary care visits
Defined from EHR data
Number of dementia-related laboratory tests performed
Defined from EHR data
Number of dementia-related neuroimaging tests performed
Defined from EHR data
Number of specialty visits or referrals for dementia assessment
Defined from EHR data
Percent of participants who receive new medications for dementia
Defined from medication orders or dispensings in the electronic health record
Number of urgent care and emergency department visits
Defined from EHR data
Number of inpatient days
Defined from EHR data
Number of scheduled visits missed
Clinic "no shows"
Proportion of days covered for current prescriptions
Standard measure of medication adherence
New dementia diagnosis (secondary definitions)
Rate of new dementia diagnosis identified from the electronic health record (EHR) using prespecified set of ICD-10 codes
New dementia diagnosis (secondary definitions)
Rate of new dementia diagnosis identified from the electronic health record (EHR) using prespecified set of ICD-10 codes
New diagnosis of mild cognitive impairment
Rate of new diagnosis of mild cognitive impairment following the intervention, defined from EHR data
Proportion of people offered a brain health visit who accept and attend the visit
Rate of accepting brain health visit
Positive predictive value of eRADAR algorithm
Proportion of people with a high risk eRADAR Score who attend a brain health visit who are diagnosed with dementia

Full Information

First Posted
June 6, 2023
Last Updated
June 14, 2023
Sponsor
University of California, San Francisco
Collaborators
Kaiser Permanente Washington, National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05905796
Brief Title
The Brain Health Study: A Pragmatic, Patient-Centered Trial
Acronym
eRADAR
Official Title
Low-cost Detection of Dementia Using Electronic Health Records Data: Validation and Testing of the Electronic Health Record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Algorithm in a Pragmatic, Patient-centered Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 7, 2022 (Actual)
Primary Completion Date
March 31, 2025 (Anticipated)
Study Completion Date
September 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
Kaiser Permanente Washington, National Institute on Aging (NIA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.
Detailed Description
Detailed description: eRADAR stands for "electronic health record (EHR) Risk of Alzheimer's and Dementia Assessment Rule." It is a low-cost tool or algorithm that uses readily available EHR data elements to identify high-risk patients. The investigators will conduct a pragmatic randomized controlled trial to assess the impact of implementing eRADAR as part of a supported outreach process on dementia detection rates. The investigators will also explore the impact of eRADAR implementation on healthcare utilization and patient experience.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dementia, Alzheimer Disease

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1350 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Brain Health Intervention
Arm Type
Experimental
Arm Description
Calculate eRADAR scores using EHR data to identify eligible individuals Invite eligible individuals for brain health assessment visit Enter results of brain health assessment visit into EHR Provide summary of results and recommended next steps to the Primary Care Physician and participant
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Usual care Individuals who meet eligibility criteria will receive usual care.
Intervention Type
Other
Intervention Name(s)
Brain Health Assessment
Intervention Description
Research interventionists, who will be trained and licensed health practitioners (e.g., social workers), will ask participants about changes in memory or thinking and daily function, screen for depression, and administer a standard cognitive screening test. Research interventionalists will use a standardized note template to document results in the participant's EHR. Research interventionists will notify participants and PCPs if follow-up is recommended.
Primary Outcome Measure Information:
Title
New dementia diagnosis
Description
Rate of new dementia diagnosis identified from the electronic health record (EHR) using prespecified set of ICD-10 codes
Time Frame
12 months after index date
Secondary Outcome Measure Information:
Title
Number of primary care visits
Description
Defined from EHR data
Time Frame
6 months after index date
Title
Number of dementia-related laboratory tests performed
Description
Defined from EHR data
Time Frame
6 months after index date
Title
Number of dementia-related neuroimaging tests performed
Description
Defined from EHR data
Time Frame
6 months after index date
Title
Number of specialty visits or referrals for dementia assessment
Description
Defined from EHR data
Time Frame
6 months after index date
Title
Percent of participants who receive new medications for dementia
Description
Defined from medication orders or dispensings in the electronic health record
Time Frame
6 months after index date
Title
Number of urgent care and emergency department visits
Description
Defined from EHR data
Time Frame
1 year after index date
Title
Number of inpatient days
Description
Defined from EHR data
Time Frame
1 year after index date
Title
Number of scheduled visits missed
Description
Clinic "no shows"
Time Frame
1 year after index date
Title
Proportion of days covered for current prescriptions
Description
Standard measure of medication adherence
Time Frame
1 year after index date
Title
New dementia diagnosis (secondary definitions)
Description
Rate of new dementia diagnosis identified from the electronic health record (EHR) using prespecified set of ICD-10 codes
Time Frame
6 months after index date
Title
New dementia diagnosis (secondary definitions)
Description
Rate of new dementia diagnosis identified from the electronic health record (EHR) using prespecified set of ICD-10 codes
Time Frame
18 months after index date
Title
New diagnosis of mild cognitive impairment
Description
Rate of new diagnosis of mild cognitive impairment following the intervention, defined from EHR data
Time Frame
12 months after index date
Title
Proportion of people offered a brain health visit who accept and attend the visit
Description
Rate of accepting brain health visit
Time Frame
3 months after invitation mailed
Title
Positive predictive value of eRADAR algorithm
Description
Proportion of people with a high risk eRADAR Score who attend a brain health visit who are diagnosed with dementia
Time Frame
12 months after index date

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia Active patient at participating clinic Adequate data to calculate eRADAR score Exclusion Criteria: - Currently receiving hospice care
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alana Elop, MS
Phone
415-361-3602
Email
alana.elop@ucsf.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Leonardo Colemon, MA
Phone
206-287-2877
Email
Leonardo.X.Colemon@kp.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Deborah Barnes, PhD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sascha Dublin, MD, PhD
Organizational Affiliation
KP Washington Health Research Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
UCSF Primary Care at China Basin
City
San Francisco
State/Province
California
ZIP/Postal Code
94107
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nghe Yang, MD
Email
nghe.yang@ucsf.edu
Facility Name
Division of General Internal Medicine
City
San Francisco
State/Province
California
ZIP/Postal Code
94115
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leah Karliner, MD
Email
leah.karliner@ucsf.edu
First Name & Middle Initial & Last Name & Degree
Elisabeth Askin, MD
Email
elisabeth.askin@ucsf.edu
Facility Name
Women's Health Primary Care
City
San Francisco
State/Province
California
ZIP/Postal Code
94143
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Judith Walsh, MD
Email
judith.walsh@ucsf.edu

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Plan description: This Individual Participant Data (IPD) plan applies to all quantitative study data, such as data collected specifically for the study and those derived from electronic health records (EHR), as well as the data collected via planned study surveys, which include only short qualitative free-text fields. The investigators do not plan to share transcripts from in-depth qualitative interviews or recorded study assessment visits. Data will be maintained on secure servers behind the firewalls at the two study sites: Kaiser Permanente Washington (KPWA) and the University of California, San Francisco (UCSF). De-identified or limited datasets containing individual-level data on which publications are based will be made available to qualified researchers for specified analyses. The investigators will make the data available to users only under a data-use agreement (DUA).
IPD Sharing Time Frame
Data can be requested after the primary study paper is accepted for publication, up until 5 years after study completion.
IPD Sharing Access Criteria
Individuals interested in using KPWA data will be required to complete a standard form, sign a Data Use Agreement (DUA) and provide documentation of IRB approval. Data may then be accessed by qualified researchers via KPWA's Secure File Transfer (SFT) site. User registration will be required in order to access or download data files. As part of the registration process, users must agree to the conditions of use governing access to the data, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, and proper acknowledgment of the data resource. Individuals interested in using UCSF data will be required to complete the same data request form. The UCSF Industry Contracts Division (ICD), which oversees incoming and outgoing transfer of all UCSF data, will review the form for compliance with UCSF policies.
Citations:
PubMed Identifier
28849435
Citation
Lee SJ, Larson EB, Dublin S, Walker R, Marcum Z, Barnes D. A Cohort Study of Healthcare Utilization in Older Adults with Undiagnosed Dementia. J Gen Intern Med. 2018 Jan;33(1):13-15. doi: 10.1007/s11606-017-4162-3. No abstract available.
Results Reference
background

Learn more about this trial

The Brain Health Study: A Pragmatic, Patient-Centered Trial

We'll reach out to this number within 24 hrs